Fig. 6

a CRT and HMGB1 staining of 4T1 tumor sites after different treatments (scale bar: 100 µm). b Representative flow cytometric assay of mature DCs (CD11c⁺CD80⁺CD86⁺) in tumor-draining lymph nodes after various treatments. c Quantitative data of mature DCs in lymph nodes corresponding to (c) (n = 3). d Representative flow cytometric assay of CD4⁺ and CD8⁺ T cells in tumor after various treatments (gated on CD3⁺ T cells). e Quantitative data of cytotoxic T cells in tumor corresponding to (d) (n = 3). f, g Serum levels of TNF-α and IL-6 after different treatments (n = 5). **P < 0.01, ***P < 0.001